Last updated on March 2019

Study for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients

Brief description of study

The purpose of this study is to compare the efficacy and safety of maribavir to valganciclovir for the treatment of cytomegalovirus (CMV) infection in asymptomatic hematopoietic stem cell transplant recipients.

Clinical Study Identifier: NCT02927067

Find a site near you

Start Over

Hopital de Hautepierre

Strasbourg Cedex, France
  Connect »